Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis

Free Subscription Articles published in Arch Virol Retrieve available abstracts of 63 articles: HTML format Text format

Single Articles

August 2019
1. PONDE RAA
   Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity.
   Arch Virol. 2019 Aug 9. pii: 10.1007/s00705-019-04369.
   PubMed     Text format     Abstract available
   
   
   
2. HUSSEINI AA, Saeed KMI, Yurdcu E, Sertoz R, et al
   Epidemiology of blood-borne viral infections in Afghanistan.
   Arch Virol. 2019;164:2083-2090.
   PubMed     Text format     Abstract available
   
   
   July 2019
3. DONYAVI T, Bokharaei-Salim F, Khanaliha K, Sheikh M, et al
   High prevalence of occult hepatitis C virus infection in injection drug users with HIV infection.
   Arch Virol. 2019 Jul 25. pii: 10.1007/s00705-019-04353.
   PubMed     Text format     Abstract available
   
   
   
4. PRATA TVG, Silva DSRD, Manchiero C, Dantas BP, et al
   MTTP polymorphisms and hepatic steatosis in individuals chronically infected with hepatitis C virus.
   Arch Virol. 2019 Jul 18. pii: 10.1007/s00705-019-04352.
   PubMed     Text format     Abstract available
   
   
   
5. DOGADOV DI, Korzaya LI, Kyuregyan KK, Karlsen AA, et al
   Natural infection of captive cynomolgus monkeys (Macaca fascicularis) with hepatitis E virus genotype 4.
   Arch Virol. 2019 Jul 3. pii: 10.1007/s00705-019-04337.
   PubMed     Text format     Abstract available
   
   
   
6. LIMERES MJ, Gomez ER, Noseda DG, Cerrudo CS, et al
   Impact of hepatitis B virus genotype F on in vitro diagnosis: detection efficiency of HBsAg from Amerindian subgenotypes F1b and F4.
   Arch Virol. 2019 Jul 2. pii: 10.1007/s00705-019-04332.
   PubMed     Text format     Abstract available
   
   
   June 2019
7. BETTAIEB J, Chouikha A, Khedhiri M, Kharroubi G, et al
   Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study.
   Arch Virol. 2019 Jun 10. pii: 10.1007/s00705-019-04308.
   PubMed     Text format     Abstract available
   
   
   May 2019
8. TIAN Z, Wang M, Yao N, Yang S, et al
   Expression of autophagy-modulating genes in peripheral blood mononuclear cells from familial clustering patients with chronic hepatitis B virus infection.
   Arch Virol. 2019 May 17. pii: 10.1007/s00705-019-04248.
   PubMed     Text format     Abstract available
   
   
   
9. WANG M, Liao Q, Xu R, Song D, et al
   Hepatitis C virus 3b strains in injection drug users in Guangdong Province, China, may have originated in Yunnan Province.
   Arch Virol. 2019 May 7. pii: 10.1007/s00705-019-04260.
   PubMed     Text format     Abstract available
   
   
   April 2019
10. MEKKY RY, El-Ekiaby N, El Sobky SA, Elemam NM, et al
    Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models.
    Arch Virol. 2019 Apr 4. pii: 10.1007/s00705-019-04232.
    PubMed     Text format     Abstract available
    
    
    March 2019
11. DEBAT HJ, Ng TFF
    Complete genome sequence of a divergent strain of Tibetan frog hepatitis B virus associated with a concave-eared torrent frog (Odorrana tormota).
    Arch Virol. 2019 Mar 28. pii: 10.1007/s00705-019-04227.
    PubMed     Text format     Abstract available
    
    
    
12. PAUL C, Khera L, Kaul R
    Hepatitis C virus core protein interacts with cellular metastasis suppressor Nm23-H1 and promotes cell migration and invasion.
    Arch Virol. 2019 Mar 11. pii: 10.1007/s00705-019-04151.
    PubMed     Text format     Abstract available
    
    
    
13. PENG TT, Cai QE, Yang M, Chen SP, et al
    Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates.
    Arch Virol. 2019 Mar 8. pii: 10.1007/s00705-019-04190.
    PubMed     Text format     Abstract available
    
    
    February 2019
14. SCHLOTTAU K, Fereidouni S, Beer M, Hoffmann B, et al
    Molecular identification and characterization of nonprimate hepaciviruses in equines.
    Arch Virol. 2019;164:391-400.
    PubMed     Text format     Abstract available
    
    
    January 2019
15. DENG H, Liang S, Liu H, Xu M, et al
    Genetic characterization of a novel unique recombinant form of HIV-1 originating from subtype A1 and C in Guangdong Province, China.
    Arch Virol. 2019;164:285-290.
    PubMed     Text format     Abstract available
    
    
    December 2018
16. ZANG F, Yue M, Zhuo L, Wu J, et al
    Correction to: Association of CXCR2 genotype variations with HCV clearance in a Chinese population.
    Arch Virol. 2018 Dec 8. pii: 10.1007/s00705-018-4111.
    PubMed     Text format     Abstract available
    
    
    November 2018
17. SEVIC I, Elizalde MM, Gonzalez Lopez Ledesma MM, Flichman DM, et al
    Analysis of fitness differences of hepatitis B virus genotypes D and F using a cotransfection assay.
    Arch Virol. 2018 Nov 12. pii: 10.1007/s00705-018-4090.
    PubMed     Text format     Abstract available
    
    
    
18. CHEN L, Zhang Y, Zhang S, Chen Y, et al
    A novel T-cell epitope in the transmembrane region of the hepatitis B virus envelope protein responds upon dendritic cell expansion.
    Arch Virol. 2018 Nov 10. pii: 10.1007/s00705-018-4095.
    PubMed     Text format     Abstract available
    
    
    
19. MATCZUK AK, Cwiek K, Wieliczko A
    Avian hepatitis E virus is widespread among chickens in Poland and belongs to genotype 2.
    Arch Virol. 2018 Nov 3. pii: 10.1007/s00705-018-4089.
    PubMed     Text format     Abstract available
    
    
    
20. SHEIKH M, Bokharaei-Salim F, Monavari SH, Ataei-Pirkooh A, et al
    Molecular diagnosis of occult hepatitis C virus infection in Iranian injection drug users.
    Arch Virol. 2018 Nov 2. pii: 10.1007/s00705-018-4066.
    PubMed     Text format     Abstract available
    
    
    October 2018
21. LI D, Chen Q, Tao C
    BCP/PC mutation prevalence and their association with HBV replication in HIV/HBV co-infected patients.
    Arch Virol. 2018;163:2829-2833.
    PubMed     Text format     Abstract available
    
    
    September 2018
22. HOFFMANN TW, Delfosse F, Helle F, Francois C, et al
    Correction to: The expression of HCV-associated host factors is dependent on the hepatoma cell line used in HCV studies.
    Arch Virol. 2018 Sep 27. pii: 10.1007/s00705-018-4044.
    PubMed     Text format     Abstract available
    
    
    
23. TANG WF, Kong DG, Wang YH, Liu MQ, et al
    Hepatitis E virus infection in Wuhan, Central China.
    Arch Virol. 2018 Sep 18. pii: 10.1007/s00705-018-4036.
    PubMed     Text format     Abstract available
    
    
    
24. MIRAZO S, D Albora C, Quintero Gil D, Cabrera K, et al
    A case of incidental infection of Hepatitis E virus (HEV) genotype 1 in a domestic pig.
    Arch Virol. 2018 Sep 15. pii: 10.1007/s00705-018-4025.
    PubMed     Text format     Abstract available
    
    
    July 2018
25. ABD ALLA MDA, El Awady MK, Dawood RM, Elhawary MA, et al
    Hepatitis C virus serologic relapse after treatment with direct-acting antivirals is dependent on viral RNA levels in peripheral blood mononuclear cells and the grade of liver cirrhosis.
    Arch Virol. 2018 Jul 3. pii: 10.1007/s00705-018-3922.
    PubMed     Text format     Abstract available
    
    
    
26. YANG C, Wang L, Shen H, Zheng Y, et al
    Detection and genomic characterization of new avian-like hepatitis E virus in a sparrow in the United States.
    Arch Virol. 2018 Jul 3. pii: 10.1007/s00705-018-3925.
    PubMed     Text format     Abstract available
    
    
    
27. YACOUBI L, Brichler S, Le Gal F, Triki H, et al
    Molecular characterization of the full-length genome sequences of HDV strains circulating in Tunisia.
    Arch Virol. 2018;163:1727-1731.
    PubMed     Text format     Abstract available
    
    
    June 2018
28. MOREIRA RC, de Torres Santos AP, Lisboa-Neto G, Mendes-Correa MCJ, et al
    Prevalence of naturally occurring amino acid substitutions associated with resistance to hepatitis C virus NS3/NS4A protease inhibitors in Sao Paulo state.
    Arch Virol. 2018 Jun 30. pii: 10.1007/s00705-018-3920.
    PubMed     Text format     Abstract available
    
    
    
29. ZANG F, Yue M, Zhuo L, Wu J, et al
    Association of CXCR2 genotype variations with HCV clearance in a Chinese population.
    Arch Virol. 2018 Jun 8. pii: 10.1007/s00705-018-3872.
    PubMed     Text format     Abstract available
    
    
    
30. HAMDY S, Osman AM, Zakaria ZA, Galal I, et al
    Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.
    Arch Virol. 2018 Jun 2. pii: 10.1007/s00705-018-3893.
    PubMed     Text format     Abstract available
    
    
    
31. TAJIK Z, Bokharaei-Salim F, Ghorbani S, Keyvani H, et al
    Detection of HBV genome in the plasma and peripheral blood mononuclear cells of Iranian HBsAg negative patients with HIV infection: occult HBV infection.
    Arch Virol. 2018;163:1559-1566.
    PubMed     Text format     Abstract available
    
    
    May 2018
32. SULCZEWSKI FB, Liszbinski RB, Romao PRT, Rodrigues Junior LC, et al
    Nanoparticle vaccines against viral infections.
    Arch Virol. 2018 May 4. pii: 10.1007/s00705-018-3856.
    PubMed     Text format     Abstract available
    
    
    March 2018
33. ELHELW DS, Riad SE, Shawer H, El-Ekiaby N, et al
    Correction to: Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
    Arch Virol. 2018 Mar 24. pii: 10.1007/s00705-018-3798.
    PubMed     Text format     Abstract available
    
    
    
34. FRAGOSO-FONSECA DE, Escobar-Escamilla N, Lloret Y Sanchez LT, Wong-Arambula CE, et al
    Full genome and phylogenetic analysis of hepatitis B virus genotype F in Mexican isolates.
    Arch Virol. 2018 Mar 16. pii: 10.1007/s00705-018-3813.
    PubMed     Text format     Abstract available
    
    
    February 2018
35. MOZHGANI SH, Malekpour SA, Norouzi M, Ramezani F, et al
    Molecular evolution and phylodynamics of hepatitis B virus infection circulating in Iran.
    Arch Virol. 2018 Feb 13. pii: 10.1007/s00705-018-3764.
    PubMed     Text format     Abstract available
    
    
    
36. WANG H, Xin X, Wang M, Han L, et al
    Myxovirus resistance protein A inhibits hepatitis C virus replication through JAK-STAT pathway activation.
    Arch Virol. 2018 Feb 7. pii: 10.1007/s00705-018-3748.
    PubMed     Text format     Abstract available
    
    
    
37. BEHZADIFAR M, Gorji HA, Bragazzi NL
    The prevalence of hepatitis C virus infection in thalassemia patients in Iran from 2000 to 2017: a systematic review and meta-analysis.
    Arch Virol. 2018 Feb 6. pii: 10.1007/s00705-018-3767.
    PubMed     Text format     Abstract available
    
    
    
38. PRIMADHARSINI PP, Mulyanto, Wibawa IDN, Anggoro J, et al
    The identification and characterization of novel rat hepatitis E virus strains in Bali and Sumbawa, Indonesia.
    Arch Virol. 2018 Feb 5. pii: 10.1007/s00705-018-3736.
    PubMed     Text format     Abstract available
    
    
    
39. ZHU DY, Deng XZ, Zhu YM, Li GT, et al
    Association of IL-28B, TBX21 gene polymorphisms and predictors of virological response for chronic hepatitis C.
    Arch Virol. 2018 Feb 5. pii: 10.1007/s00705-018-3750.
    PubMed     Text format     Abstract available
    
    
    January 2018
40. YU JM, Li LL, Xie GC, Zhang CY, et al
    Experimental infection of Marmota monax with a novel hepatitis A virus.
    Arch Virol. 2018 Jan 31. pii: 10.1007/s00705-018-3715.
    PubMed     Text format     Abstract available
    
    
    
41. NAEEMI H, Aslam R, Raza SM, Shahzad MA, et al
    Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.
    Arch Virol. 2018 Jan 16. pii: 10.1007/s00705-018-3711.
    PubMed     Text format     Abstract available
    
    
    
42. YAN Y, Li C, Sun B, Yang R, et al
    DCAF1 is involved in HCV replication through regulation of miR-122.
    Arch Virol. 2018 Jan 11. pii: 10.1007/s00705-017-3691.
    PubMed     Text format     Abstract available
    
    
    
43. BOGLIONE L, Cusato J, Pinna SM, De Nicolo A, et al
    Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens.
    Arch Virol. 2018 Jan 9. pii: 10.1007/s00705-017-3684.
    PubMed     Text format     Abstract available
    
    
    December 2017
44. ISHIBASHI M, Yamaguchi H, Hirotani Y, Sakurada A, et al
    Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
    Arch Virol. 2017 Dec 16. pii: 10.1007/s00705-017-3675.
    PubMed     Text format     Abstract available
    
    
    
45. HARA J, Tanaka Y, Kaneko H, Itoh Y, et al
    Detection of hepatitis B virus DNA and HBsAg from postmortem blood and bloodstains.
    Arch Virol. 2017 Dec 2. pii: 10.1007/s00705-017-3665.
    PubMed     Text format     Abstract available
    
    
    November 2017
46. SILVA FQ, Santos FJA, Andrade AP, Pacheco SDB, et al
    Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon.
    Arch Virol. 2017 Nov 21. doi: 10.1007/s00705-017-3656.
    PubMed     Text format     Abstract available
    
    
    
47. YANG S, Xing H, Feng S, Ju W, et al
    Prevalence of NS5B resistance-associated variants in treatment-naive Asian patients with chronic hepatitis C.
    Arch Virol. 2017 Nov 15. doi: 10.1007/s00705-017-3640.
    PubMed     Text format     Abstract available
    
    
    
48. GORI A, Gheorgita S, Spinu C, Pinzaru I, et al
    Hepatitis B, C and D virus genotypes detected in HBsAg- or anti-HCV-positive people from the Republic of Moldova.
    Arch Virol. 2017 Nov 8. doi: 10.1007/s00705-017-3632.
    PubMed     Text format     Abstract available
    
    
    
49. DE MIRANDA BKB, de Sa KSG, da Silva ANR, Feitosa RNM, et al
    GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4+ T lymphocyte count.
    Arch Virol. 2017;162:3431-3438.
    PubMed     Text format     Abstract available
    
    
    October 2017
50. BADFAR G, Shohani M, Nasirkandy MP, Mansouri A, et al
    Epidemiology of hepatitis B in pregnant Iranian women: a systematic review and meta-analysis.
    Arch Virol. 2017 Oct 23. doi: 10.1007/s00705-017-3551.
    PubMed     Text format     Abstract available
    
    
    
51. NGUYEN LT, Van Nguyen D, Carr MJ, Hall WW, et al
    Association of interferon lambda polymorphisms with elevated baseline viral loads in chronic hepatitis C virus genotype 6 infection.
    Arch Virol. 2017 Oct 11. doi: 10.1007/s00705-017-3583.
    PubMed     Text format     Abstract available
    
    
    
52. ABD-ELSALAM S, Sharaf-Eldin M, Soliman S, Elfert A, et al
    Efficacy and safety of sofosbuvir plus ribavirin for treatment of cirrhotic patients with genotype 4 hepatitis C virus in real-life clinical practice.
    Arch Virol. 2017 Oct 5. doi: 10.1007/s00705-017-3573.
    PubMed     Text format     Abstract available
    
    
    September 2017
53. FERREIRA AC, Gomes-Gouvea MS, Lisboa-Neto G, Mendes-Correa MCJ, et al
    Serological and molecular markers of hepatitis E virus infection in HIV-infected patients in Brazil.
    Arch Virol. 2017 Sep 30. doi: 10.1007/s00705-017-3562.
    PubMed     Text format     Abstract available
    
    
    
54. RAMIREZ-SOTO MC, Bracho MA, Gonzalez-Candelas F, Huichi-Atamari M, et al
    Genotypes and subgenotypes of hepatitis B virus circulating in an endemic area in Peru.
    Arch Virol. 2017 Sep 25. doi: 10.1007/s00705-017-3557.
    PubMed     Text format     Abstract available
    
    
    
55. PONDE RAA
    The serological markers of acute infection with hepatitis A, B, C, D, E and G viruses revisited.
    Arch Virol. 2017 Sep 7. doi: 10.1007/s00705-017-3538.
    PubMed     Text format     Abstract available
    
    
    July 2017
56. YOUSSEF SS, Hamdy NM
    SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4.
    Arch Virol. 2017 Jul 31. doi: 10.1007/s00705-017-3498.
    PubMed     Text format     Abstract available
    
    
    
57. DAUD M, Rana MA, Husnain T, Ijaz B, et al
    Modulation of Wnt signaling pathway by hepatitis B virus.
    Arch Virol. 2017 Jul 6. doi: 10.1007/s00705-017-3462.
    PubMed     Text format     Abstract available
    
    
    June 2017
58. ELHELW DS, Riad SE, Shawer H, El-Ekiaby N, et al
    Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of Occludin.
    Arch Virol. 2017 Jun 22. doi: 10.1007/s00705-017-3449.
    PubMed     Text format     Abstract available
    
    
    
59. QU C, Xu L, Yin Y, Peppelenbosch MP, et al
    Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.
    Arch Virol. 2017 Jun 16. doi: 10.1007/s00705-017-3444.
    PubMed     Text format     Abstract available
    
    
    
60. LI S, Xie M, Li W, Peng Q, et al
    Prevalence of S gene mutations within the major hydrophilic region of hepatitis B virus in patients in Dongguan, southern China.
    Arch Virol. 2017 Jun 9. doi: 10.1007/s00705-017-3437.
    PubMed     Text format     Abstract available
    
    
    May 2017
61. CATTOIR L, Van Hoecke F, Van Maerken T, Nys E, et al
    Hepatitis E virus serology and PCR: does the methodology matter?
    Arch Virol. 2017 May 18. doi: 10.1007/s00705-017-3395.
    PubMed     Text format     Abstract available
    
    
    April 2017
62. RODRIGUEZ LAY LLA, Bello Corredor M, Montalvo Villalba MC, Chibas Ojeda AG, et al
    Hepatitis B virus infection assessed 3 to 18 years after vaccination in Cuban children and adolescents born to HBsAg-positive mothers.
    Arch Virol. 2017 Apr 24. doi: 10.1007/s00705-017-3365.
    PubMed     Text format     Abstract available
    
    
    
63. MORSICA G, Andolina A, Merli M, Messina E, et al
    NS3 protease resistance-associated substitutions in liver tissue and plasma samples from patients infected by hepatitis C virus genotype 1A or 1B.
    Arch Virol. 2017 Apr 18. doi: 10.1007/s00705-017-3341.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: